Cardinal Health


Cardinal Health, Eli Lilly collaborate on Alzheimer’s imaging agent

Cardinal Health (NYSE:CAH) will manufacture and distribute a radioactive imaging agent from Eli Lilly (NYSE:LLY) that could help doctors diagnose Alzheimer’s disease. The imaging agent, called Amyvid, is scheduled for commercial launch on June 1, according to a statement from Dublin, Ohio-based Cardinal. Amyvid was approved by the U.S. Food and Drug Administration in April. […]


New decision-support tool to help doctors follow cancer, arthritis best practices

New decision support technology from Cardinal Health (NYSE:CAH) is designed to help physicians follow cancer and rheumatoid arthritis “clinical pathways” — evidence-based treatment regimens. The new technology, called PathWare Solutions, would be purchased by a health insurance plan or payer, which would then make it available to physicians in its network, according to a spokeswoman […]

Devices & Diagnostics

Cardinal Health to buy drug distributor Dik Drug

Consolidation in the U.S. drug distribution business continues as Cardinal Health (NYSE:CAH) has purchased a Chicago-area regional drug wholesaler, Dik Drug Company. The acquisition was first reported by Adam Fein at Drug Channels and confirmed to MedCity News in a statement from a Cardinal spokeswoman. Dublin, Ohio-based Cardinal said it signed a definitive agreement to […]